CNE1000070H8
CNE1000070H8
LEADS BIOLABS-B
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 177.255.000 | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | 177.255.000 | -- | -- |
| 370.300.000 | 265.393.000 | 39.5% | |
| Operating Income | -193.045.000 | -265.393.000 | 27.3% |
| Pretax Income | -195.893.000 | -301.216.000 | 35.0% |
| Net Income Common Stockholders | -211.419.000 | -301.216.000 | 29.8% |
| -- | -- | -- | |
| -- | -- | -- |